Stocktoria

ARDELYX, INC. ARDX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-06-19 · LEI

ARDELYX, INC. financials (annual)

Revenue
$42.0M $2.6M $5.3M $7.6M $10.1M $52.2M $124.5M $333.6M $407.3M 2016201720182019202020212022202320242025
Net income
-$112.4M -$64.3M -$91.3M -$94.9M -$94.3M -$158.2M -$67.2M -$66.1M -$39.1M -$61.6M 2016201720182019202020212022202320242025
Free cash flow
-$97.4M -$67.5M -$70.6M -$76.8M -$81.8M -$154.4M -$70.1M -$90.1M -$45.8M -$44.0M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$407.3M$333.6M$124.5M$52.2M$10.1M$7.6M$5.3M$2.6M$42.0M
Gross profit$4.7M$2.1M$33.6M
R&D expense$71.5M$52.3M$35.5M$35.2M$91.1M$65.1M$71.7M$69.4M$75.5M$94.2M
SG&A expense$337.2M$258.7M$134.4M$76.6M$72.3M
Operating income-$41.0M-$27.9M-$63.3M-$63.8M-$154.3M-$90.8M-$91.3M-$90.9M-$65.1M-$112.9M
Interest expense$5.0M$3.4M$4.5M$5.1M$5.7M$3.5M
Income tax$969,000$266,000$547,000$8,000$4,000$2,000$303,000$4,000$1.2M
Net income-$61.6M-$39.1M-$66.1M-$67.2M-$158.2M-$94.3M-$94.9M-$91.3M-$64.3M-$112.4M
EPS (diluted)$-0.26$-0.17$-0.30$-0.42$-1.52$-1.05$-1.47
Operating cash flow-$42.5M-$44.8M-$89.7M-$70.0M-$152.6M-$81.4M-$76.5M-$70.3M-$65.2M-$92.5M
Free cash flow-$44.0M-$45.8M-$90.1M-$70.1M-$154.4M-$81.8M-$76.8M-$70.6M-$67.5M-$97.4M
Cash & equivalents$68.0M$64.9M$21.5M$96.1M$72.4M$91.0M$181.1M$78.8M$75.4M$74.6M
Inventory$123.1M$91.2M$49.5M$28.3M$0
Total assets$501.6M$435.8M$297.6M$190.1M$149.9M$201.6M$259.8M$183.3M$157.9M$213.1M
Total liabilities$334.7M$262.5M$130.8M$91.7M$67.3M$75.5M$73.1M$67.5M$18.6M$20.0M
Shareholders' equity$166.9M$173.3M$166.8M$98.3M$82.6M$126.1M$186.7M$115.8M$139.3M$193.2M

Growth · year-over-year · Revenue CAGR 32.8%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+22.1%+168.1%+138.6%+416.6%+33.4%+43.4%+102.6%-93.8%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.